JORDAN BEAVERSON: Open Payments
NPI 1578933693 · NAPLES, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$500 in 17 payments from 11 companies in 2025. Trend: 2023 $283 · 2024 $111 · 2025 $500
Food & beverage: $500
| Company | Payments | Amount |
|---|---|---|
| Edwards Lifesciences Corporation | 1 | $173 |
| Amgen Inc. | 5 | $84 |
| Novo Nordisk Inc | 2 | $49 |
| Cleerly, Inc. | 1 | $34 |
| Novartis Pharmaceuticals Corporation | 2 | $32 |
| BridgeBio Pharma, Inc. | 1 | $26 |
| AstraZeneca Pharmaceuticals LP | 1 | $22 |
| Lilly USA, LLC | 1 | $21 |
| Terumo Medical Corporation | 1 | $21 |
| PFIZER INC. | 1 | $20 |
Products named: REPATHA, Wegovy, ELIQUIS, Cleerly Ischemia, LEQVIO, Attruby, FARXIGA, MOUNJARO.
Industry payments across FL — which companies pay providers there.
